Task: Answer the multiple-choice question.
Query: Which drug exhibits a 16.587\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCOc1ccc2ncc(C(=O)c3ccc(OC)cc3)c(N3CCN(CC)CC3)c2c1
[b] O=C(O)C(Cc1ccccc1)n1c(=S)[nH]c2ccccc2c1=O
Answer: b. O=C(O)C(Cc1ccccc1)n1c(=S)[nH]c2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(O)C(Cc1ccccc1)n1c(=S)[nH]c2ccccc2c1=O
O=C(O)C(Cc1ccccc1)n1c(=S)[nH]c2ccccc2c1=O
2-(4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)-3-phenylpropanoicacid